anmelden
25 € WM-Startbonus auf dein Cash-Konto
OMX Nordic 40
2.665,22
PKT
-34,37
PKT
-1,27
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.05.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 09.05.25 | Novo Nordisk Buy | UBS AG | |
| 08.05.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 08.05.25 | Novo Nordisk Halten | DZ BANK | |
| 08.05.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.05.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | AstraZeneca Halten | DZ BANK | |
| 30.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 29.04.25 | Nokia Buy | Deutsche Bank AG | |
| 29.04.25 | AstraZeneca Buy | UBS AG | |
| 28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.04.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 26.04.25 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
| 25.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 25.04.25 | Volvo (B) Outperform | RBC Capital Markets | |
| 24.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 24.04.25 | Nokia Market-Perform | Bernstein Research | |
| 24.04.25 | Volvo (B) Underperform | Bernstein Research | |
| 24.04.25 | Nokia Neutral | UBS AG | |
| 24.04.25 | Volvo (B) Buy | Deutsche Bank AG | |
| 24.04.25 | Nokia Underweight | Barclays Capital | |
| 24.04.25 | Nokia Hold | Jefferies & Company Inc. | |
| 23.04.25 | Volvo (B) Buy | UBS AG |